Opportunities for Patient Centricity in Life Sciences

Play this Episode

Patient centricity is no longer a buzzword, it’s redefining how the pharmaceutical industry operates to deliver the best outcomes and experiences for patients. In this episode, Jen is joined by Vynamic London team members Gemma Pfister and Jack Young to discuss opportunities to become more patient centric throughout the medicine development lifecycle. Inclusiveness, empowerment, and partnership are defining featured of a truly patient centric approach (00:41). There are opportunities for improving patient centricity across the entire lifecycle of a product, from development (03:13) to reimbursement (08:35) to commercialization (12:50). Pharmaceutical companies are uniquely positioned to drive and derive value from patient centricity efforts (19:25), but success in the space requires a focus on strategy, digital, and measurement (21:52). Read how Vynamic partnered with a global pharmaceutical company to help change the way the life sciences industry develops patient-focused solutions in the future in our Case Study – Building an Industry-Changing Patient Innovation Hub.

Podcast Tags: patient centricity, patient advocacy, life sciences, pharmaceutical, pharma, HTA

Source Links:

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Gemma Pfister, Executive & London Hub Lead

[email protected]


Jack Young, Director

[email protected]

Jen Burke, Healthcare Industry Strategist

[email protected]

Want to learn more? Get in Touch!

Contact our team to learn more about how we can help your needs.

Let's Talk

Send us a message and we'll get back to you shortly.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.